A detailed history of Wsfs Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wsfs Capital Management, LLC holds 7,272 shares of BMY stock, worth $413,122. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,272
Previous 7,272 -0.0%
Holding current value
$413,122
Previous $302,000 24.5%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $175,885 - $209,879
-3,628 Reduced 33.28%
7,272 $373,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $261,315 - $292,191
4,514 Added 70.69%
10,900 $632,000
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $161,950 - $179,821
2,542 Added 66.13%
6,386 $408,000
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $7,162 - $8,123
-109 Reduced 2.76%
3,844 $266,000
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $270,701 - $320,548
3,953 New
3,953 $284,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $188,633 - $220,960
-3,188 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $197,369 - $214,934
3,188 New
3,188 $213,000
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $205,138 - $230,720
-3,457 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $16,941 - $18,773
-295 Reduced 7.86%
3,457 $208,000
Q1 2020

May 01, 2020

SELL
$46.4 - $67.43 $12,342 - $17,936
-266 Reduced 6.62%
3,752 $209,000
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $197,725 - $257,915
4,018 New
4,018 $258,000
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $187,921 - $243,688
-3,854 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $41,006 - $46,251
-743 Reduced 16.16%
3,854 $239,000
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $1,414 - $1,763
28 Added 0.61%
4,597 $254,000
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $61,537 - $70,842
-1,027 Reduced 18.35%
4,569 $289,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $309,067 - $356,689
5,596
5,596 $357,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wsfs Capital Management, LLC Portfolio

Follow Wsfs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wsfs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wsfs Capital Management, LLC with notifications on news.